Genmab News

Truist Financial Keeps Their Buy Rating on Genmab (GMAB)

TipRanksApr 9 07:35 ET

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), AbbVie (ABBV) and Immunome (IMNM)

TipRanksApr 8 03:50 ET

Genmab Analyst Ratings

BenzingaApr 4 11:24 ET

Analysts' Top Healthcare Picks: Paragon 28 (FNA), Genmab (GMAB)

TipRanksApr 4 10:30 ET

Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX) and Genmab (GMAB)

TipRanksMar 27 06:30 ET

Analyst Ratings For Genmab

BenzingaMar 26 10:00 ET

Genmab Analyst Ratings

BenzingaMar 26 09:26 ET

Truist Financial Remains a Buy on Genmab (GMAB)

TipRanksMar 26 08:45 ET

Genmab Analyst Ratings

BenzingaMar 6 08:02 ET

Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Springworks Therapeutics (SWTX) and Genmab (GMAB)

TipRanksMar 6 06:40 ET

Truist Financial Reaffirms Their Buy Rating on Genmab (GMAB)

TipRanksMar 1 07:35 ET

BMO Upgrades Genmab to Outperform, Cites Diversification Potential

Seeking AlphaFeb 23 14:08 ET

Genmab Analyst Ratings

BenzingaFeb 23 05:55 ET

Genmab (GMAB) Gets a Buy From Truist Financial

TipRanksFeb 22 21:25 ET

Genmab Analyst Ratings

BenzingaFeb 20 07:20 ET

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), BioMarin Pharmaceutical (BMRN) and Greenwich LifeSciences (GLSI)

TipRanksFeb 20 06:30 ET

Analysts Conflicted on These Healthcare Names: Genmab (GMAB), CbdMD (YCBD) and SAGE Therapeutics (SAGE)

TipRanksFeb 15 08:03 ET

BMO Capital Reaffirms Their Hold Rating on Genmab (GMAB)

TipRanksFeb 15 07:10 ET

Maintaining Hold on Genmab: Balancing Darzalex Success With GEN3014's Uncertain Future and Competitive Market Risks

TipRanksFeb 13 05:22 ET

Genmab Analyst Ratings

BenzingaJan 29 06:39 ET